Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy (SMART) in Asthma Patients Across Asia: SMARTASIA

NCT00939341 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00939341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00939341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy (SMART) in Asthma Patients Across Asia: SMARTASIA
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2009
Completion date
August 31, 2010
Enrollment
862 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

asthma